Can a simple genetic test get more people on heart-saving statins?

NCT ID NCT07260552

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at whether giving patients and their doctors a polygenic risk score — a genetic test that estimates future risk of coronary heart disease — helps more people start taking statins to prevent heart problems. Researchers will enroll 200 adults aged 40-69 without prior heart disease or statin use from rural and urban clinics. Half will get the genetic risk score along with standard risk assessment; the other half will get standard assessment alone. The main goal is to see if the genetic information leads to more statin prescriptions and lower cholesterol.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

polygenic risk score (genetic screening tool)

What this could lead to

If successful, this could show that using a genetic risk test in primary care helps more people start preventive medication and lower their heart disease risk.

What could go wrong

This is a small, early-stage study focused on feasibility and uptake, not on actual heart attacks or deaths. The genetic test may not change behavior or outcomes in real-world settings.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CORONARY HEART DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

coronary artery disorder Coronary Disease Genetic Risk Score

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••